BusinessFactor Therapeutics Announces Commencement of Phase II Trial of a Novel Topical Biologic for the Treatment of Chronic WoundsBy Nasdaq OMXDec 20, 2016, 2:00 PM UTC
BusinessSANUWAVE Health to Attend Upcoming Trade Shows and Medical ConferencesBy Nasdaq OMXMar 16, 2016, 1:00 PM UTC